Explore how AI accelerates antibody discovery by enabling de novo design, epitope prediction, and in silico affinity maturation for highly specific, developable therapeutics.
Learn how deep learning and structure-based models optimize antibody stability, immunogenicity and target binding to advance precision biologics.
Explore how ML-enabled real-time control systems and continuous process verification improve yield predictability, reduce rework, and enable faster release - offering a direct line of sight to cost savings and product quality gains.
Veera is currently managing a team of 40+ scientists, establishing robotics, lab automation predictive analytics and advanced chemometrics in next generation biologics manufacturing at AstraZeneca. He has 25+ years of experience, with expertise crossing R&D, manufacturing operations and supply chain.
Strategic insights from complex, high-dimensional healthcare data, fostering integrated analytics and strengthening the organization’s competitive edge in precision medicine.
Showcasing generative models that craft hyper‑personalized outreach messages and informed consent materials, driving up engagement rates and shaving weeks off recruitment timelines.
Discover how ML‑driven forecasts for recruitment rates and optimized site selection translate into faster first‑patient‑in and lower screen‑fail/dropout rates, saving you both time and budget.
Learn how AI models enhance physics-based simulations to predict molecular interactions and optimize drug design.
Discover the synergy between machine learning and classical methods to accelerate screening and improve the accuracy of drug discovery.
Explore how AI enhances biomarker discovery by analyzing large datasets to uncover novel biomarkers for disease diagnosis and therapeutic efficacy.
Learn how integrating digital biomarkers with AI improves the interpretation of data from wearable devices and traditional lab-based biomarkers for better patient stratification and treatment personalization.
Examine how AI models are being developed, validated, and governed to meet regulatory expectations, with practical insights into documentation, auditability, and lifecycle management to ensure safe, transparent, and compliant deployment in GxP environments.
Guides strategic IT decisions by clarifying trade-offs between cloud and on-premise solutions, to align infrastructure strategy with agility, security, and compliance objectives.
Explore practical strategies for scaling AI implementation across clinical development pipelines, enabling faster trial execution, smarter protocol design, and improved patient recruitment while aligning with evolving regulatory expectations.
Explore h ow AI models predict protein 3D structures from sequences, enabling insights into folding pathways and functional conformations
Examine emerging co-folding models that reveal protein–protein interactions and guide multimeric complex design.
